What is NDC 70771-1917?

70771-1917 is the product NDC for gabapentin, Gabapentin 750 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

gabapentin NDC 70771-1917 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1917Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1917Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1917-1	7077119170170771191701	100 TABLET in 1 BOTTLE (70771-1917-1)Marketed from Sep 18, 2025
70771-1917-6	7077119170670771191706	60 TABLET in 1 BOTTLE (70771-1917-6)Marketed from Sep 18, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 750 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203934
Marketing start: Sep 18, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 70771-1917_ba40713a-2f22-4276-a664-355e7442cda4SPL ID ba40713a-2f22-4276-a664-355e7442cda4SPL set ID 8c0eeefc-ef5b-49f4-8411-ddbae312ed05RxCUI 1806380, 1806382, 2634743, 2634747, 2634751UNII 6CW7F3G59XUPC 0368382608161, 0368382607164

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771191701 followed by a unit qualifier and the quantity

Package 70771-1917-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 15, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1917

What is NDC 70771-1917?: 70771-1917 is the product NDC for gabapentin, Gabapentin 750 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for gabapentin?: 561 other product NDCs are listed under this name. See all gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-0070518-4740-01
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 gabapentin NDCs

Other NDCs under ANDA 203934

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203934
Product	Strength	Form · route	Labeler	Product NDC
gabapentin	Gabapentin 450 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-355
gabapentin	Gabapentin 750 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-356
gabapentin	Gabapentin 900 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-357
gabapentin	Gabapentin 600 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-607
gabapentin	Gabapentin 300 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-608
gabapentin	Gabapentin 300 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1861
gabapentin	Gabapentin 600 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1862
gabapentin	Gabapentin 450 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1916
gabapentin	Gabapentin 900 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1918